[Pubmed] Thyrotoxic myopathy: research status, diagnosis, and treatment

[RSS-Bot]

Endokrynol Pol. 2022 Feb 4. doi: 10.5603/EP.a2022.0004. Online ahead of print.

ABSTRACT

Thyrotoxic myopathy is hyperthyroidism accompanied by muscle lesions. It is recognized as the general term for a group of symptoms with several main manifestations of several hyperthyroidism patients in the course (e.g. muscle weakness, muscle paralysis, or pain). From the clinical perspective, it may only be manifested as muscle-related symptoms. The symptoms of high metabolic syndrome (e.g. thyrotoxicosis) are absent, obscured, or relatively delayed, so it can be easily misdiagnosed. Accordingly, patients experiencing the first symptom of myopathy should concentrate on the possibility of thyrotoxic myopathy. Given the clinical characteristics, thyrotoxic myopathy can be devided into chronic thyrotoxic myopathy, thyrotoxicosis with periodic paralysis, acute thyrotoxic myopathy, hyperthyroidism with myasthenia gravis, as well as infiltrating exophthalmos with ophthalmoplegia. In this paper, we review thyrotoxic myopathy research status, diagnoses, and treatments.

PMID:35119093 | DOI:10.5603/EP.a2022.0004


Source: https://pubmed.ncbi.nlm.nih.gov/3511909 ... 3&v=2.17.5